Overcoming the Extracellular Matrix Barrier to Nanoparticle Transport

Abstract

The extracellular matrix (ECM) is a major component of the tumor microenvironment which poses a significant barrier to nanoparticle (NP) transport, preventing delivery of therapeutic cargo. Studies have shown that PEGylation offers an effective strategy for improving NP transport in ECM. However, these studies have generally used ECM models that are not wholly representative of the native matrix. Furthermore, while ECM characteristics and composition varies across organs, it is unclear to what extent these tissue-specific characteristics affect NP transport through the ECM and how NP surface chemistry impacts ECM penetration in distinct tissues. The overall objective of this dissertation is to identify key factors of NP transport through the tumor microenvironment, facilitating the development of strategies to improve NP distribution throughout the tumor microenvironment. We hypothesized that PEG branching will enhance stability and mobility of NPs in ECM and that ECM source impacts NP transport. We further hypothesized that PEG architecture significantly affects NP mobility in ECM as well as biodistribution and tumor accumulation in vivo. Our first aim was to determine the effects of PEG branching on NP stability and transport through in vitro basement membrane model. We found that branched PEG significantly increased both the stability and mobility of NPs in Matrigel, a basement membrane model. We then assessed the impact of tissue source on NP transport through an in vitro ECM model. We decellularized porcine lung, liver, and small intestine submucosa to form tissue specific hydrogels and found NP mobility was significantly impacted by tissue source where low molecular weight linear PEG generally provided the greatest benefit to NP mobility within the different matrices. Finally, we evaluated how PEG branching affects biodistribution, immune cell infiltration, and NP uptake in tumors in vivo. We found that NPs coated with branched PEG increased NP accumulation within tumors and PEGylation significantly impacted immune cell infiltration within these tumors. This work provides additional insight into the transport mechanisms of NPs throughout the tumor microenvironment as well as additional considerations for the design of efficient NP delivery systems.